BMS-241027
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BMS-241027, covering 2014-07-24 to 2014-07-24. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety, Tolerability and the Effect of BMS-241027 on Cerebrospinal Fluid Biomarkers in Subjects With Mild Alzheimer's Disease [Phase 1]